Shannon Campbell

Insider Reports History

Entity
Individual
Location
C/O Black Diamond Therapeutics, Inc., One Main Street, 14 Th Floor, Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shannon Campbell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Director Common Stock 8.87K $22.2K $2.50 Dec 13, 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30.6K Jun 6, 2024 Direct

Insider Reports Filed by Shannon Campbell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Dec 13, 2024 1 $11.3K 4 Dec 16, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Sep 20, 2024 1 $11.3K 4 Sep 20, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Jun 21, 2024 1 $10K 4 Jun 21, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Apr 10, 2024 1 $0 4 Apr 12, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Apr 10, 2024 0 $0 3 Apr 12, 2024 Director